A detailed history of Birmingham Capital Management CO Inc/Al transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Birmingham Capital Management CO Inc/Al holds 47,941 shares of BMY stock, worth $2.75 Million. This represents 0.91% of its overall portfolio holdings.

Number of Shares
47,941
Previous 45,141 6.2%
Holding current value
$2.75 Million
Previous $1.87 Million 32.34%
% of portfolio
0.91%
Previous 0.73%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Dec 10, 2024

BUY
$39.66 - $51.75 $111,047 - $144,900
2,800 Added 6.2%
47,941 $2.48 Million
Q2 2024

Aug 28, 2024

BUY
$40.25 - $52.99 $56,994 - $75,033
1,416 Added 3.24%
45,141 $1.87 Million
Q1 2024

May 29, 2024

SELL
$47.98 - $54.4 $15,113 - $17,136
-315 Reduced 0.72%
43,725 $2.37 Million
Q4 2023

Feb 20, 2024

SELL
$48.48 - $57.85 $2,569 - $3,066
-53 Reduced 0.12%
44,040 $2.26 Million
Q3 2023

Dec 13, 2023

SELL
$57.89 - $64.73 $34,734 - $38,838
-600 Reduced 1.34%
44,093 $2.56 Million
Q2 2023

Sep 19, 2023

BUY
$63.71 - $70.74 $9,875 - $10,964
155 Added 0.35%
44,693 $2.86 Million
Q1 2023

May 22, 2023

BUY
$65.71 - $74.53 $8,213 - $9,316
125 Added 0.28%
44,538 $3.09 Million
Q1 2022

Apr 29, 2022

SELL
$61.48 - $73.72 $70,702 - $84,778
-1,150 Reduced 2.52%
44,413 $3.24 Million
Q4 2021

Feb 11, 2022

BUY
$53.63 - $62.52 $8,473 - $9,878
158 Added 0.35%
45,563 $2.84 Million
Q3 2021

Dec 20, 2021

SELL
$59.17 - $69.31 $29,585 - $34,655
-500 Reduced 1.09%
45,405 $2.69 Million
Q2 2021

Aug 02, 2021

BUY
$61.91 - $67.42 $1,857 - $2,022
30 Added 0.07%
45,905 $3.07 Million
Q1 2021

Apr 30, 2021

BUY
$59.34 - $66.74 $25,219 - $28,364
425 Added 0.94%
45,875 $2.9 Million
Q4 2020

Feb 03, 2021

SELL
$57.74 - $65.43 $25,405 - $28,789
-440 Reduced 0.96%
45,450 $2.82 Million
Q3 2020

Oct 30, 2020

BUY
$57.43 - $63.64 $10,050 - $11,137
175 Added 0.38%
45,890 $2.77 Million
Q2 2020

Aug 07, 2020

SELL
$54.82 - $64.09 $21,928 - $25,636
-400 Reduced 0.87%
45,715 $2.69 Million
Q1 2020

Apr 28, 2020

SELL
$46.4 - $67.43 $208,800 - $303,435
-4,500 Reduced 8.89%
46,115 $2.57 Million
Q4 2019

Feb 03, 2020

SELL
$49.21 - $64.19 $19,684 - $25,676
-400 Reduced 0.78%
50,615 $3.25 Million
Q3 2019

Nov 05, 2019

SELL
$42.77 - $50.71 $72,709 - $86,207
-1,700 Reduced 3.22%
51,015 $2.59 Million
Q2 2019

Aug 05, 2019

SELL
$44.62 - $49.34 $63,940 - $70,704
-1,433 Reduced 2.65%
52,715 $2.39 Million
Q1 2019

Apr 25, 2019

SELL
$45.12 - $53.8 $41,736 - $49,765
-925 Reduced 1.68%
54,148 $2.58 Million
Q4 2018

Jan 30, 2019

SELL
$48.76 - $63.23 $246,238 - $319,311
-5,050 Reduced 8.4%
55,073 $2.86 Million
Q3 2018

Nov 19, 2018

SELL
$55.19 - $62.25 $355,975 - $401,512
-6,450 Reduced 9.69%
60,123 $3.73 Million
Q2 2018

Jul 20, 2018

SELL
$50.53 - $62.98 $50,530 - $62,980
-1,000 Reduced 1.48%
66,573 $3.68 Million
Q1 2018

Apr 24, 2018

SELL
$59.92 - $68.98 $179,760 - $206,940
-3,000 Reduced 4.25%
67,573 $4.27 Million
Q4 2017

Feb 08, 2018

BUY
$59.94 - $65.35 $4.23 Million - $4.61 Million
70,573
70,573 $4.33 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $122B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Birmingham Capital Management CO Inc/Al Portfolio

Follow Birmingham Capital Management CO Inc/Al and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Birmingham Capital Management CO Inc/Al, based on Form 13F filings with the SEC.

News

Stay updated on Birmingham Capital Management CO Inc/Al with notifications on news.